Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 1/2011

01.02.2011 | Research Article

Convergence of tuberculosis and diabetes mellitus: time to individualise pharmaceutical care

verfasst von: Shubashini Gnanasan, Kang Nee Ting, Kok Thong Wong, Salmiah Mohd Ali, Abdul Razak Muttalif, Claire Anderson

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Objective To assess the feasibility of providing a pharmacist-led pharmaceutical care service to patients with tuberculosis and diabetes mellitus. Setting The study was conducted at a tertiary hospital in the northern region of Peninsular Malaysia. Methods Action research methodology was used. Main outcome measure Pharmaceutical care issues. Results The prevalence of diabetes mellitus among newly diagnosed tuberculosis patients was 15% (53/352). Out of 53 patients identified, 35 participated in the study. Patients’ ages ranged between 29 and 73 years (mean of 52 ± 10 years). The male: female ratio was 1.7:1. Pharmaceutical care issues identified by pharmacists were nonadherence, uncontrolled diabetes mellitus, adverse drug reactions and individual patient’s medication related problems. Pharmacists were able to intervene and resolve some of the pharmaceutical care issues. Conclusion Pharmacists played an important role in integrating the provision of care for tuberculosis and diabetes mellitus by providing individualised pharmaceutical care management. There still remains a need to address logistic barriers that impinged on the ability to conduct the pharmaceutical care service to its full potential.
Literatur
1.
Zurück zum Zitat Harries DA, Murray MB, Jeon CY, Ottmani SE, Lonnroth K, Barreto ML, et al. Defining the research agenda to reduce the joint burden of disease from Diabetes mellitus and Tuberculosis. Trop Med Int Health. 2010;15:659–63.PubMedCrossRef Harries DA, Murray MB, Jeon CY, Ottmani SE, Lonnroth K, Barreto ML, et al. Defining the research agenda to reduce the joint burden of disease from Diabetes mellitus and Tuberculosis. Trop Med Int Health. 2010;15:659–63.PubMedCrossRef
2.
Zurück zum Zitat Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2,000 and projections for 2030. Diabetes Care. 2004;27:1047–53.PubMedCrossRef Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2,000 and projections for 2030. Diabetes Care. 2004;27:1047–53.PubMedCrossRef
4.
Zurück zum Zitat Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis. 2009;9:737–46.PubMedCrossRef Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis. 2009;9:737–46.PubMedCrossRef
5.
Zurück zum Zitat Wang CS, Yang CJ, Chen HC, Chuang SH, Chong IW, Hwang JJ, et al. Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis. Epidemiol Infect. 2009;137:203–10.PubMedCrossRef Wang CS, Yang CJ, Chen HC, Chuang SH, Chong IW, Hwang JJ, et al. Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis. Epidemiol Infect. 2009;137:203–10.PubMedCrossRef
6.
Zurück zum Zitat Stevenson CR, Forouhi NG, Roglic G, Williams BG, Lauer JA, Dye C, et al. DM and tuberculosis: the impact of the DM epidemic on tuberculosis incidence. BMC Public Health. 2007;7:234.PubMedCrossRef Stevenson CR, Forouhi NG, Roglic G, Williams BG, Lauer JA, Dye C, et al. DM and tuberculosis: the impact of the DM epidemic on tuberculosis incidence. BMC Public Health. 2007;7:234.PubMedCrossRef
7.
Zurück zum Zitat Dooley KE, Tang T, Golub JE, Dorman SE, Cronin W. Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg. 2009;80:634–9.PubMed Dooley KE, Tang T, Golub JE, Dorman SE, Cronin W. Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg. 2009;80:634–9.PubMed
8.
Zurück zum Zitat Nissapatorn V, Kuppusamy I, Jamaiah I, Fong MY, Rohela M, Khairul Annuar A. Tuberculosis in diabetes patients: A clinical perspective. Southeast Asian J Trop Med Public Health. 2005;36:213–20.PubMed Nissapatorn V, Kuppusamy I, Jamaiah I, Fong MY, Rohela M, Khairul Annuar A. Tuberculosis in diabetes patients: A clinical perspective. Southeast Asian J Trop Med Public Health. 2005;36:213–20.PubMed
9.
Zurück zum Zitat Bashar M, Alcabes P, Rom WN, Condos R. Increased incidence of multi-drug resistant tuberculosis in diabetic patients on the Bellevue Chest Service, 1987 to 1997. Chest. 2001;120:1514–9.PubMedCrossRef Bashar M, Alcabes P, Rom WN, Condos R. Increased incidence of multi-drug resistant tuberculosis in diabetic patients on the Bellevue Chest Service, 1987 to 1997. Chest. 2001;120:1514–9.PubMedCrossRef
10.
Zurück zum Zitat Chan JCN, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301:2129–40.PubMedCrossRef Chan JCN, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301:2129–40.PubMedCrossRef
11.
Zurück zum Zitat Rampal S, Rampal L, Rahmat R, Md Zain A, Yee GL, Mohamed M, et al. Variation in the prevalence, awareness, and control of diabetes in a multiethnic population: a nationwide population study in Malaysia. Asia Pac J Public Health. 2010;22:194–202.PubMed Rampal S, Rampal L, Rahmat R, Md Zain A, Yee GL, Mohamed M, et al. Variation in the prevalence, awareness, and control of diabetes in a multiethnic population: a nationwide population study in Malaysia. Asia Pac J Public Health. 2010;22:194–202.PubMed
13.
Zurück zum Zitat Odegard PS, Gray SL. Barriers to medication adherence in poorly controlled diabetes mellitus. Diabetes Educ. 2008;34:692–7.PubMedCrossRef Odegard PS, Gray SL. Barriers to medication adherence in poorly controlled diabetes mellitus. Diabetes Educ. 2008;34:692–7.PubMedCrossRef
14.
Zurück zum Zitat Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J. Patient adherence to tuberculosis treatment: A systematic review of qualitative research. PLoS Med. 2007;4:1230–45.CrossRef Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J. Patient adherence to tuberculosis treatment: A systematic review of qualitative research. PLoS Med. 2007;4:1230–45.CrossRef
15.
Zurück zum Zitat World Health Organisation. An expanded DOTS framework for effective tuberculosis contro. Int J Tuberc Lung Dis. 2002;6:378–88. World Health Organisation. An expanded DOTS framework for effective tuberculosis contro. Int J Tuberc Lung Dis. 2002;6:378–88.
16.
Zurück zum Zitat Gnanasan S, Wong KT, Mohd Ali S, Ting KN, Anderson C. Pharmacist-led medication therapy adherence clinic: exploring views of health care professionals. Int J Pharm Pract. 2010;18(Suppl 1):S24–5. Gnanasan S, Wong KT, Mohd Ali S, Ting KN, Anderson C. Pharmacist-led medication therapy adherence clinic: exploring views of health care professionals. Int J Pharm Pract. 2010;18(Suppl 1):S24–5.
17.
Zurück zum Zitat Townsend A, Hunt K, Wyke S. Managing multiple morbidity in mid-life: a qualitative study of attitudes to drug use. BMJ. 2003;327:837–40.PubMedCrossRef Townsend A, Hunt K, Wyke S. Managing multiple morbidity in mid-life: a qualitative study of attitudes to drug use. BMJ. 2003;327:837–40.PubMedCrossRef
18.
Zurück zum Zitat Tulip S, Campbell D. Evaluating pharmaceutical care in hospitals. Hosp Pharm. 2001;8:275–9. Tulip S, Campbell D. Evaluating pharmaceutical care in hospitals. Hosp Pharm. 2001;8:275–9.
19.
Zurück zum Zitat Medical Research Coucil. A framework for development and evaluation of RCTs for complex interventions to improve health. London: MRC. 2000. Medical Research Coucil. A framework for development and evaluation of RCTs for complex interventions to improve health. London: MRC. 2000.
20.
Zurück zum Zitat Gnanasan S, Ting KN, Wong KT, Mohd Ali S, Muttalif AR, Anderson C. Medication beliefs and concerns among patients with tuberculosis and diabetes mellitus. 16th international social pharmacy workshop. Pharm Pract (Internet). 2010;8(Suppl 1):1–136. Gnanasan S, Ting KN, Wong KT, Mohd Ali S, Muttalif AR, Anderson C. Medication beliefs and concerns among patients with tuberculosis and diabetes mellitus. 16th international social pharmacy workshop. Pharm Pract (Internet). 2010;8(Suppl 1):1–136.
21.
Zurück zum Zitat Gnanasan S, Wong KT, Mohd Ali S, Muttalif AR, Ting KN, Anderson C. Exploring the need for pharmaceutical care (PC) management of tuberculosis and diabetes mellitus (TBDM) in Malaysia. Abstracts of the PCNE 7th Working Conference. Pharm World Sci. 2009;31:503. Gnanasan S, Wong KT, Mohd Ali S, Muttalif AR, Ting KN, Anderson C. Exploring the need for pharmaceutical care (PC) management of tuberculosis and diabetes mellitus (TBDM) in Malaysia. Abstracts of the PCNE 7th Working Conference. Pharm World Sci. 2009;31:503.
22.
Zurück zum Zitat Meyer J. Qualitative research in health care. Using qualitative methods in health related action research. BMJ. 2000;320:178–81.PubMedCrossRef Meyer J. Qualitative research in health care. Using qualitative methods in health related action research. BMJ. 2000;320:178–81.PubMedCrossRef
23.
Zurück zum Zitat Hart E, Bond M. Action research for health and social care: a guide to practice: Buckingham: Open University Press. 1995. Hart E, Bond M. Action research for health and social care: a guide to practice: Buckingham: Open University Press. 1995.
24.
Zurück zum Zitat Tanna NK. Action Research: a valuable research technique for service delivery development. Pharm World Sci. 2005;27:4–6.PubMedCrossRef Tanna NK. Action Research: a valuable research technique for service delivery development. Pharm World Sci. 2005;27:4–6.PubMedCrossRef
25.
Zurück zum Zitat Gilbert AL, Roughead EE, Beilby J, Mott K, Barratt JD. Collaborative medication management services: improving patient care. Med J Aust. 2002;177:189–92.PubMed Gilbert AL, Roughead EE, Beilby J, Mott K, Barratt JD. Collaborative medication management services: improving patient care. Med J Aust. 2002;177:189–92.PubMed
26.
Zurück zum Zitat Tanna N, Pitkin J, Anderson C. Development of the specialist menopause pharmacist (SMP) role within a research framework. Pharm World Sci. 2005;27:61–7.PubMedCrossRef Tanna N, Pitkin J, Anderson C. Development of the specialist menopause pharmacist (SMP) role within a research framework. Pharm World Sci. 2005;27:61–7.PubMedCrossRef
27.
Zurück zum Zitat Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–43.PubMed Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–43.PubMed
28.
Zurück zum Zitat Clark PM, Karagoz T, Apikoglu-Rabus S, Vehbi IF. Effect of pharmacist-led patient education on adherence to tuberculosis treatment. Am J Health Syst Pharm. 2007;64:497–506.PubMedCrossRef Clark PM, Karagoz T, Apikoglu-Rabus S, Vehbi IF. Effect of pharmacist-led patient education on adherence to tuberculosis treatment. Am J Health Syst Pharm. 2007;64:497–506.PubMedCrossRef
29.
Zurück zum Zitat Mitrzyk BM. Treatment of extensively drug-resistant tuberculosis and role of the pharmacist. Pharmacotherapy. 2008;28:1243–54.PubMedCrossRef Mitrzyk BM. Treatment of extensively drug-resistant tuberculosis and role of the pharmacist. Pharmacotherapy. 2008;28:1243–54.PubMedCrossRef
30.
Zurück zum Zitat Elliott RA, Ross-Degnan D, Adans AS, Safran DG, Soumerai SB. Strategies for coping in a complex world: Adherence behavior among older adults with chronic illness. J Gen Intern Med. 2007;22:805–10.PubMedCrossRef Elliott RA, Ross-Degnan D, Adans AS, Safran DG, Soumerai SB. Strategies for coping in a complex world: Adherence behavior among older adults with chronic illness. J Gen Intern Med. 2007;22:805–10.PubMedCrossRef
31.
32.
Zurück zum Zitat Marra CA, Marra F, Cox VC, Palepu A, Fitzgerald M. Factors influencing quality of life in patients with active tuberculosis. Health Qual Life Outcomes 2004;2. 58 doi:10.1186/1477-7525-2-58. Marra CA, Marra F, Cox VC, Palepu A, Fitzgerald M. Factors influencing quality of life in patients with active tuberculosis. Health Qual Life Outcomes 2004;2. 58 doi:10.​1186/​1477-7525-2-58.​
33.
Zurück zum Zitat Benson J, Britten N. Patients’ decisions about whether or not to take antihypertensive drugs: qualitative study. BMJ. 2002;325:873–6.PubMedCrossRef Benson J, Britten N. Patients’ decisions about whether or not to take antihypertensive drugs: qualitative study. BMJ. 2002;325:873–6.PubMedCrossRef
34.
Zurück zum Zitat Gordon K, Smith F, Dhillon S. Effective chronic disease management: patients’ perspectives on education-related problems. Patient Educ Couns. 2007;65:407–15.PubMedCrossRef Gordon K, Smith F, Dhillon S. Effective chronic disease management: patients’ perspectives on education-related problems. Patient Educ Couns. 2007;65:407–15.PubMedCrossRef
35.
Zurück zum Zitat Pound P, Britten N, Morgan M, Yardley L, Pope C, Daker-White G, et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med. 2005;61:133–55.PubMedCrossRef Pound P, Britten N, Morgan M, Yardley L, Pope C, Daker-White G, et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med. 2005;61:133–55.PubMedCrossRef
36.
Zurück zum Zitat Rao PV. Persons with type 2 diabetes and co-morbid active tuberculosis should be treated with insulin. Int J Diabetes Dev Ctries. 1999;19:79–86. Rao PV. Persons with type 2 diabetes and co-morbid active tuberculosis should be treated with insulin. Int J Diabetes Dev Ctries. 1999;19:79–86.
37.
Zurück zum Zitat Kotokey RK, Bhattaharya D, Das P, Azad A, De A. Study of efficacy of DOTS in pulmonary tuberculosis patients with associated diabetes. Lung India. 2007;24:58–60.CrossRef Kotokey RK, Bhattaharya D, Das P, Azad A, De A. Study of efficacy of DOTS in pulmonary tuberculosis patients with associated diabetes. Lung India. 2007;24:58–60.CrossRef
38.
39.
Zurück zum Zitat Chandran M, Chu NV, Edelman SV. Gastrointestinal disturbances in diabetes. Curr Diab Rep. 2003;3:43–8.PubMedCrossRef Chandran M, Chu NV, Edelman SV. Gastrointestinal disturbances in diabetes. Curr Diab Rep. 2003;3:43–8.PubMedCrossRef
40.
Zurück zum Zitat Javadi MR, Shalviri G, Gholami K, Salamzadeh J, Maghooli G, Mirsaeedi SM. Adverse reactions of anti-tuberculosis drugs in hospitalized patients: incidence, severity and risk factors. Pharmacoepidemiol Drug Saf. 2007;16:1104–10.PubMedCrossRef Javadi MR, Shalviri G, Gholami K, Salamzadeh J, Maghooli G, Mirsaeedi SM. Adverse reactions of anti-tuberculosis drugs in hospitalized patients: incidence, severity and risk factors. Pharmacoepidemiol Drug Saf. 2007;16:1104–10.PubMedCrossRef
41.
Zurück zum Zitat Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, Menzies D. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med. 2003;167:1472–7.PubMedCrossRef Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, Menzies D. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med. 2003;167:1472–7.PubMedCrossRef
42.
Zurück zum Zitat Piette JD, Heisler M, Wagner TH. Cost-related medication underuse: do patients with chronic illnesses tell their doctors? Arch Intern Med. 2004;164:1749–55.PubMedCrossRef Piette JD, Heisler M, Wagner TH. Cost-related medication underuse: do patients with chronic illnesses tell their doctors? Arch Intern Med. 2004;164:1749–55.PubMedCrossRef
Metadaten
Titel
Convergence of tuberculosis and diabetes mellitus: time to individualise pharmaceutical care
verfasst von
Shubashini Gnanasan
Kang Nee Ting
Kok Thong Wong
Salmiah Mohd Ali
Abdul Razak Muttalif
Claire Anderson
Publikationsdatum
01.02.2011
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 1/2011
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-010-9452-3

Weitere Artikel der Ausgabe 1/2011

International Journal of Clinical Pharmacy 1/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.